The approval of Casgevy opens the door to new possibilities in treating genetic diseases.
The approval of Casgevy opens the door to new possibilities in treating genetic diseases. The successful application of CRISPR technology in this context underscores the potential for gene editing to revolutionize medicine, offering hope for diseases once considered untreatable. However, the challenges of affordability and accessibility remain significant hurdles that need addressing to fully realize the potential of this groundbreaking treatment​​​​.